Browse our anti-Oncostatin M (OSM) Antibodies

Full name:
anti-Oncostatin M Antibodies (OSM)
On are 208 Oncostatin M (OSM) Antibodies from 24 different suppliers available. Additionally we are shipping Oncostatin M Proteins (75) and Oncostatin M Kits (63) and many more products for this protein. A total of 357 Oncostatin M products are currently listed.
OncoM, OSM

Most Popular Reactivities for anti-Oncostatin M (OSM) Antibodies

Select your species and application

anti-Human Oncostatin M Antibodies:

anti-Mouse (Murine) Oncostatin M Antibodies:

anti-Rat (Rattus) Oncostatin M Antibodies:

All available anti-Oncostatin M Antibodies

Go to our pre-filtered search.

Top referenced anti-Oncostatin M Antibodies

  1. Human Polyclonal Oncostatin M Primary Antibody for FACS, Neut - ABIN4899954 : Ohsaka, Hirota-Komatsu, Shibata, Ezaki, Shinohara, Yoshida: Specific association of increased vascular endothelial growth factor expression and its receptors with macrophage differentiation of HL-60 leukemia cells. in Biochemical and biophysical research communications 2008 (PubMed)
    Show all 2 references for 4899954

  2. Human Polyclonal Oncostatin M Primary Antibody for ELISA (Detection), FACS - ABIN4899952 : Hurst, McLoughlin, Monslow, Owens, Morgan, Fuller, Topley, Jones: Secretion of oncostatin M by infiltrating neutrophils: regulation of IL-6 and chemokine expression in human mesothelial cells. in Journal of immunology (Baltimore, Md. : 1950) 2002 (PubMed)

  3. Human Monoclonal Oncostatin M Primary Antibody for IHC, IHC (p) - ABIN4341424 : Kang, Kim, Jang, Park, Lee, Kim: 22q11-q13 as a hot spot for prediction of disease-free survival in bile duct cancer: integrative analysis of copy number variations. in Cancer genetics 2014 (PubMed)

  4. Human Polyclonal Oncostatin M Primary Antibody for IHC, IHC (p) - ABIN4341425 : Guo, Chen, Shi, Wang, Chen, Diao, Hu, Yu, Qian, Guo: Stat3-coordinated Lin-28-let-7-HMGA2 and miR-200-ZEB1 circuits initiate and maintain oncostatin M-driven epithelial-mesenchymal transition. in Oncogene 2013 (PubMed)

More Antibodies against Oncostatin M Interaction Partners

Human Oncostatin M (OSM) interaction partners

  1. Neutrophils are a major source of OSM-producing cells in patients with chronic rhinosinusitis and severe asthma.

  2. OSM and OSMR are highly expres (show TNF Antibodies)sed in inflammatory bowel disease intestinal mucosa compared to control mucosa. OSM promotes inflammatory behavior in human intestinal stroma.

  3. Study showed that in atrial fibrillation (AF) with thrombus, the atrial tissue infiltration of M1 macrophages increased significantly; the OSM expression was also found to increase simultaneously; downstream tissue factor (show F3 Antibodies) (TF) increased and tissue factor (show F3 Antibodies) pathway inhibitors (TFPI (show TFPI Antibodies))decreased, leading to an imbalance between TF and TFPI (show TFPI Antibodies) eventually. OSM might be related to thrombosis in patients with AF mediated by TF and TFPI (show TFPI Antibodies)

  4. a novel STAT3 (show STAT3 Antibodies)/SMAD3 (show SMAD3 Antibodies)-signaling axis is required for OSM-mediated senescence.

  5. This result demonstrates that HPV16 oncoproteins upregulate oncostatin M and play an important role to promote oral squamous cell carcinoma development

  6. The identification of the OSM inflammatory pathway as an important mediator of epithelial mesenchymal transition in triple-negative breast cancer (TNBC) may provide a novel potential opportunity to improve therapeutic strategies.

  7. Nucleolin (show NCL Antibodies) stabilizes oncostatin-M mRNA by binding to a GC-rich (show RELB Antibodies) element in its 3'UTR (show UTS2R Antibodies).

  8. Oncostatin M and interleukin-31 (show IL31 Antibodies): Cytokines, receptors, signal transduction and physiology.

  9. Oncostatin M can regulate airway smooth muscle responses alone or in synergy with IL-17A (show IL17A Antibodies).

  10. we demonstrated that recombinant human OSM (rhOSM) promoted tumor angiogenesis in EC cell lines by activating STAT3 (signal transducer and activator of transcription 3 (show STAT3 Antibodies)) and enhanced both cell migration and cell inva

Mouse (Murine) Oncostatin M (OSM) interaction partners

  1. OSM mitigated the proliferation of Th17 cells and decreased the expression of IL-17 (show IL17A Antibodies) and IL-21 (show IL21 Antibodies); it promoted the activation of suppressor of cytokine signaling 3 (SOCS3 (show SOCS3 Antibodies)), STAT3 (show STAT3 Antibodies), and STAT5 (show STAT5A Antibodies); observations suggest that OSM can inhibit Th17 differentiation by reciprocally controlling SOCS3 (show SOCS3 Antibodies), STAT3 (show STAT3 Antibodies), and STAT5 (show STAT5A Antibodies)

  2. In an animal model of anti-TNF (show TNF Antibodies)-resistant intestinal inflammation, genetic deletion or pharmacological blockade of OSM significantly attenuates colitis.

  3. these results support the proinflammatory role of OSM when it is overexpressed in the skin. However, OSM expression was not required in the murine model of psoriasis induced by topical application of imiquimod, as demonstrated by the inflammatory phenotype of OSM-deficient mice or wild-type mice treated with anti-OSM antibodies.

  4. OSM (mOSM) signals mainly via an OSM receptor (OSMR (show OSMR PLURAL_@2410@))-gp130 (show LRPPRC PLURAL_@2410@) heterodimer and binds with only very low affinity to mLIFR.

  5. Loss of Oncostatin M Signaling in Adipocytes Induces Insulin (show INS Antibodies) Resistance and Adipose Tissue Inflammation in Vivo.

  6. mechanism of OSM-induced cardiomyocyte dedifferentiation is associated with B-Raf (show SNRPE Antibodies)/Mek (show MDK Antibodies)/Erk (show EPHB2 Antibodies) signaling pathway through the OSM receptor Obeta

  7. Oncostatin M and interleukin-31 (show IL31 Antibodies): Cytokines, receptors, signal transduction and physiology.

  8. OSM plays multiple critical roles in the maintenance and development of the hematopoietic microenvironment in the bone marrow at a steady state as well as after injury.

  9. OSM treatment preserved cardiac function, inhibited apoptosis and fibrosis, and stimulated angiogenesis via upregulating VEGF (show VEGFA Antibodies) and bFGF (show FGF2 Antibodies) in infarct border zone of ischemic myocardium, indicating that OSM could be a novel therapeutic target for MI.

  10. The mechanism of Oncostatin M on cardiac ischemia/reperfusion injury is partly mediated by the Notch3 (show NOTCH3 Antibodies)/Akt (show AKT1 Antibodies) pathway.

Cow (Bovine) Oncostatin M (OSM) interaction partners

  1. Protein kinase R plays a pivotal role in oncostatin M and interleukin-1 signalling in bovine articular cartilage chondrocytes.

Oncostatin M (OSM) Antigen Profile

Antigen Summary

Oncostatin M is a member of a cytokine family that includes leukemia-inhibitory factor, granulocyte colony-stimulating factor, and interleukin 6. This gene encodes a growth regulator which inhibits the proliferation of a number of tumor cell lines. It regulates cytokine production, including IL-6, G-CSF and GM-CSF from endothelial cells.

Alternative names and synonyms associated with Oncostatin M (OSM)

  • oncostatin M (OSM) antibody
  • oncostatin M (Osm) antibody
  • oncostatin M-like (LOC100342491) antibody
  • oncostatin-M-like (LOC100152038) antibody
  • OncoM antibody
  • OSM antibody

Protein level used designations for anti-Oncostatin M (OSM) Antibodies

oncostatin M , oncostatin-M

736338 Pan troglodytes
5008 Homo sapiens
18413 Mus musculus
289747 Rattus norvegicus
319086 Bos taurus
100724699 Cavia porcellus
611921 Canis lupus familiaris
101122466 Ovis aries
100342491 Oryctolagus cuniculus
100152038 Sus scrofa
Selected quality suppliers for anti-Oncostatin M (OSM) Antibodies
Did you look for something else?